☆ 4.6 Review

Infection fatality rate of COVID-19 in community-dwelling elderly populations

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2022)

Related references

Note: Only part of the references are listed.

Article Geriatrics & Gerontology

Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic ( VIVALDI study): prospective cohort study in England

Maria Krutikov et al.

Summary: This study investigated the prevalence and antibody decline in staff and residents of long-term care facilities in England. The findings showed that at least a quarter of staff and a third of surviving residents were infected with SAR-CoV-2. The nucleocapsid-specific antibodies became undetectable within the first year following infection, leading to significant underestimation of the true proportion of people with previous infection. Better assays should be developed to identify natural infection.

LANCET HEALTHY LONGEVITY (2022)

Add to Collection

Article Public, Environmental & Occupational Health

Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England

Maria Krutikov et al.

Summary: This study investigated the prevalence and stability of nucleocapsid antibodies in staff and residents of LTCFs in England, finding that at least a quarter of staff and a third of surviving residents were infected with SAR-CoV-2 during the first two waves of the pandemic. Moreover, it was shown that nucleocapsid-specific antibodies often become undetectable within the first year following infection, leading to potential underestimation of the true proportion of people with previous infection.

LANCET GLOBAL HEALTH (2022)

Add to Collection

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare Setting

Ellen C. Hughes et al.

Summary: Identifying risk factors for SARS-CoV-2 exposure and quantifying population immunity are crucial for future epidemic preparedness. A serosurvey in Scotland found that secondary care patients, male patients, and individuals aged 45-64 had a higher probability of being seropositive, with some developing highly neutralizing antibodies.

JOURNAL OF INFECTIOUS DISEASES (2021)

Add to Collection

Article Public, Environmental & Occupational Health

COVID-19 antibody seroprevalence in Santa Clara County, California

Eran Bendavid et al.

Summary: The study found that the estimated prevalence of SARS-CoV-2 antibodies in Santa Clara County was 2.8% after weighting, indicating that COVID-19 was likely more widespread than indicated by the number of cases at that time. This suggests that low-burden contexts like Santa Clara County were still far from herd immunity thresholds by late March 2020.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2021)

Add to Collection

Article Allergy

Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19

Carlo Cervia et al.

Summary: The study found that severe COVID-19 patients experienced a significant increase in SARS-CoV-2 antibody titers after symptom onset, especially with high IgA titers, while mild cases may exhibit transient production of SARS-CoV-2-specific antibodies. Interestingly, some healthcare workers with negative serum antibody titers showed SARS-CoV-2-specific IgA in mucosal fluids with virus-neutralizing capacity in some cases.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Add to Collection

Article Geriatrics & Gerontology

Frailty and comorbidity in predicting community COVID-19 mortality in the UK Biobank: The effect of sampling

Jonathan K. L. Mak et al.

Summary: Frailty and comorbidity measures were found to be associated with COVID-19 mortality risk in a U.K. Biobank cohort study. Concurrent HFRS and CCI were shown to have stronger predictive abilities for COVID-19 mortality, but limited added value in COVID-19 inpatients.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2021)

Add to Collection

Article Hematology

SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada

Sahar Saeed et al.

Summary: This study estimated the seroprevalence of SARS-CoV-2 antibodies among blood donors in Canada and found regional and ethnic disparities. This has important implications for evaluating public health policies and monitoring disparities.

TRANSFUSION (2021)

Add to Collection

Article Environmental Sciences

Racial and Ethnic Disparities in Years of Potential Life Lost Attributable to COVID-19 in the United States: An Analysis of 45 States and the District of Columbia

Jay J. Xu et al.

Summary: The study found significant racial/ethnic disparities in COVID-19 attributable YPLL across states in the United States, with non-Hispanic Blacks and Hispanics experiencing disproportionately high YPLL and non-Hispanic Whites experiencing disproportionately low YPLL. The disparities were more pronounced when measuring YPLL compared to death counts, especially in younger age groups. Additionally, there was substantial state-to-state variability in the magnitudes of the estimated racial/ethnic disparities, suggesting a connection to social determinants of health that vary by state.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Add to Collection

Review Public, Environmental & Occupational Health

Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis

Xinhua Chen et al.

Summary: This study synthesized and evaluated a large amount of global data on SARS-CoV-2 serological surveys, revealing variations in seroprevalence among different populations and in the infection-to-case ratio across regions. Most settings have not achieved herd immunity, and insights into the true proportion of infected population can be derived from serological detection data in routine confirmation.

LANCET GLOBAL HEALTH (2021)

Add to Collection

Article Geriatrics & Gerontology

The demography and characteristics of SARS-CoV-2 seropositive residents and staff of nursing homes for older adults in the Community of Madrid: the SeroSOS study

Francisco Javier Candel et al.

Summary: The study highlights the high prevalence of COVID-19 among residents in nursing homes, especially those who are frail and have comorbidities. Factors associated with seropositivity among staff include age, obesity, job type, workplace seroprevalence, and contact with external COVID-19 cases. Strengthening control measures is crucial to prevent COVID-19 transmission in care facilities.

AGE AND AGEING (2021)

Add to Collection

Article Environmental Sciences

Second versus first wave of COVID-19 deaths: Shifts in age distribution and in nursing home fatalities

John P. A. Ioannidis et al.

Summary: In the examined countries, the age distribution of COVID-19 deaths was similar in the second wave compared to the first wave, but the contribution of COVID-19 deaths in nursing home residents to total fatalities decreased in most countries in the second wave.

ENVIRONMENTAL RESEARCH (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Estimating the Cumulative Incidence of SARS-CoV-2 Infection and the Infection Fatality Ratio in Light of Waning Antibodies

Kayoko Shioda et al.

Summary: Through analysis of data from New York City and Connecticut, researchers found that serology data without adjustment for waning antibodies underestimates the cumulative incidence of SARS-CoV-2 infection. They successfully estimated the infection fatality ratio and time for antibody waning, providing a basis for adjusting estimates.

EPIDEMIOLOGY (2021)

Add to Collection

Review Medicine, General & Internal

Reconciling estimates of global spread and infection fatality rates of COVID-19: An overview of systematic evaluations

John P. A. Ioannidis

Summary: This study reviewed six systematic evaluations on the global spread and infection rate of COVID-19, finding a consensus on SARS-CoV-2 infection being widely spread globally with an average IFR of about 0.15% and an estimated 1.5-2.0 billion infections. The research highlights substantial differences in IFR and infection spread across continents, countries, and locations.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Nationwide seroprevalence of antibodies against SARS-CoV-2 in Israel

Shay Reicher et al.

Summary: The first local spread of COVID-19 in Israel was detected in March 2020, and a nationwide seroprevalence study conducted between June and September showed an overall seroprevalence of 3.8%. Males had a higher prevalence than females, with adolescents showing the highest prevalence. Participants who had undergone RT-PCR testing had a tenfold higher risk to be seropositive.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2021)

Add to Collection

Article Multidisciplinary Sciences

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Cathrine Axfors et al.

Summary: This study conducted a rapid meta-analysis on the effects of hydroxychloroquine and chloroquine on the survival of COVID-19 patients. It found that treatment with hydroxychloroquine was associated with increased mortality, while there was no benefit from chloroquine.

NATURE COMMUNICATIONS (2021)

Add to Collection

Article Multidisciplinary Sciences

Racial disparities in COVID-19 outcomes exist despite comparable Elixhauser comorbidity indices between Blacks, Hispanics, Native Americans, and Whites

Fares Qeadan et al.

Summary: This study compared the risk of different COVID-19 health outcomes among different racial groups, finding significant disparities even when comparing Elixhauser comorbidity index scores. The study found that racial disparities exist in outcomes such as hospital stay length, ventilator dependence, hospitalization risk, and death rates.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Multidisciplinary Sciences

Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic

Laith J. Abu-Raddad et al.

Summary: The study provided descriptive epidemiology of the SARS-CoV-2 epidemic in Qatar, showing age as the strongest predictor of severe, critical, or fatal infection. Most cases were asymptomatic. The rapid decline in cases was attributed to the growing immunity levels in the population.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Provisional Mortality Data - United States, 2020

Farida B. Ahmad et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Add to Collection

Article Infectious Diseases

Duration of SARS-CoV-2 sero-positivity in a large longitudinal sero-surveillance cohort: the COVID-19 Community Research Partnership

David M. Herrington et al.

Summary: This study found that approximately 50% of participants with SARS-CoV-2 infection but minimal or no symptoms experienced antibody reversion within 30 days of their initial positive test. IgM reverted more quickly than IgG. Overall, the duration of antibody response was short.

BMC INFECTIOUS DISEASES (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Prevalence of SARS-CoV-2 antibodies in Denmark: nationwide, population-based seroepidemiological study

Laura Espenhain et al.

Summary: Seroprevalence studies conducted in Denmark in 2020 have shown an increase in seroprevalence estimates throughout the year, especially in the 12-29 age group and metropolitan areas. Hospitalization rates were significantly higher in older age groups, and although many seropositive individuals were asymptomatic, loss of taste/smell was a specific symptom.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Antibody status and cumulative incidence of SARS-CoV-2 infection among adults in three regions of France following the first lockdown and associated risk factors: a multicohort study

Fabrice Carrat et al.

Summary: During May-June 2020, the seropositivity to anti-SARS-CoV-2 antibodies in the French adult population was around 10%, varying across different regions. Younger age, having children or adolescents in the household, and being a non-smoker were associated with higher seropositivity rates.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2021)

Add to Collection

Article Infectious Diseases

SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study

Ramanan Laxminarayan et al.

Summary: A large-scale SARS-CoV-2 surveillance programme in Madurai, India revealed equal risk of asymptomatic infection among children, teenagers, and working-age adults, with increasing risk of infection and death associated with older age and comorbidities.

LANCET INFECTIOUS DISEASES (2021)

Add to Collection

Article Cell Biology

Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States

Heather Kalish et al.

Summary: The study analyzed undiagnosed SARS-CoV-2 infections in the United States and found a high prevalence rate, with different seropositivity estimates among various racial, age, gender, ethnic, and urban/rural groups. Data indicated that as of mid-July 2020, there were an estimated 16.8 million undiagnosed infections in the United States, with 4.8 undiagnosed cases for every diagnosed case of COVID-19.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Microbiology

Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic

Carmen L. Charlton et al.

Summary: This study systematically evaluated the SARS-CoV-2 IgG positivity in a provincial cohort in Alberta, Canada. The results showed differences in seropositivity among different age groups, genders, income levels, and population densities.

MICROBIOLOGY SPECTRUM (2021)

Add to Collection

Article Immunology

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Fatality Rate Among Elderly Danes: A Cross-sectional Study on Retired Blood Donors

Ole Birger Pedersen et al.

Summary: By studying retired blood donors and national COVID-19 survey data, reliable population-based infection fatality rate estimates for individuals aged 70 and above were obtained, revealing that the COVID-19 infection fatality rate for this age group is 65 times higher than for those aged 18-69.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Article Infectious Diseases

COVID-19 in long-term care facilities in Brazil: serological survey in a post-outbreak setting

Eliana Nogueira Castro de Barros et al.

Summary: This study examined the seroprevalence of SARS-CoV-2 in long-term care facilities in Brazil after COVID-19 outbreaks, finding higher infection rates in facilities with previous outbreaks. Most infected residents had prior contact with confirmed COVID-19 cases. Despite low seroprevalence in the elderly population, the vulnerability of this group and the conducive environment in LTCFs for transmission highlight the need for measures to control the spread.

REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Inferring the COVID-19 infection fatality rate in the community-dwelling population: a simple Bayesian evidence synthesis of seroprevalence study data and imprecise mortality data

Harlan Campbell et al.

Summary: Estimating the infection fatality rate (IFR) of COVID-19 is challenging due to biases in death and infection data. Bayesian evidence synthesis method accounts for uncertainties. Results show lower IFR in younger and wealthier populations.

EPIDEMIOLOGY AND INFECTION (2021)

Add to Collection

Article Health Care Sciences & Services

Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults

Helen Ward et al.

Summary: The study in England examined changes in antibody positivity at the population level following the first wave of the COVID-19 epidemic. Results showed a decline in overall antibody prevalence over time, with differences in decline among different age groups and individuals with different COVID-19 history. The findings highlight the need for widespread vaccination to confer immunity and control the epidemic.

LANCET REGIONAL HEALTH-EUROPE (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Precision shielding for COVID-19: metrics of assessment and feasibility of deployment

John P. A. Ioannidis

Summary: The study found that during the first wave of COVID-19, different locations and settings varied significantly in their ability to protect high-risk groups. Some areas and settings achieved effective precision shielding, while in others detrimental inverse protection may have occurred. COVID-19 interventions should aim to achieve maximal precision shielding.

BMJ GLOBAL HEALTH (2021)

Add to Collection

Article Public, Environmental & Occupational Health

Infection fatality rate of COVID-19 inferred from seroprevalence data

John P. A. Ioannidis

Summary: This study aimed to estimate the infection fatality rate of COVID-19 using seroprevalence data. The findings showed that the infection fatality rate varied significantly across different locations due to differences in population age structure, case mix of infected and deceased patients, and other factors. The inferred infection fatality rates were generally lower than earlier estimates made during the pandemic.

BULLETIN OF THE WORLD HEALTH ORGANIZATION (2021)

Add to Collection

Article Immunology

Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France

Floriane Gallais et al.

Summary: The study found that all confirmed COVID-19 patients had SARS-CoV-2 specific antibodies and T-cell responses lasting up to 102 days after symptom onset, while their contacts remained seronegative but 6 of them reported COVID-19 symptoms within a median of 7 days and 4 of them had positive SARS-CoV-2 specific T-cell responses lasting up to 93 days after infection.

EMERGING INFECTIOUS DISEASES (2021)

Add to Collection

Review Immunology

Innate Immune Evasion by Human Respiratory RNA Viruses

Marjolein Kikkert

JOURNAL OF INNATE IMMUNITY (2020)

Add to Collection

Article Medicine, General & Internal

Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility

M. M. Arons et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Geriatrics & Gerontology

Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary

Bela Merkely et al.

GEROSCIENCE (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Seroprevalence of Specific Antibodies against SARS-CoV-2 from Hotspot Communities in the Dominican Republic

Robert Paulino-Ramirez et al.

AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)

Add to Collection

Article Biochemistry & Molecular Biology

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19

Takuya Sekine et al.

CELL (2020)

Add to Collection

Article Multidisciplinary Sciences

Factors associated with COVID-19-related death using OpenSAFELY

Elizabeth J. Williamson et al.

NATURE (2020)

Add to Collection

Article Environmental Sciences

Population-level COVID-19 mortality risk for non-elderly individuals overall and for non-elderly individuals without underlying diseases in pandemic epicenters

John P. A. Ioannidis et al.

ENVIRONMENTAL RESEARCH (2020)

Add to Collection

Article Multidisciplinary Sciences

Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital

Alberto L. Garcia-Basteiro et al.

NATURE COMMUNICATIONS (2020)

Add to Collection

Article Medicine, General & Internal

Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study

Shuchi Anand et al.

LANCET (2020)

Add to Collection

Article Medicine, General & Internal

Humoral Immune Response to SARS-CoV-2 in Iceland

Daniel F. Gudbjartsson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Environmental Sciences

Time between Symptom Onset, Hospitalisation and Recovery or Death: Statistical Analysis of Belgian COVID-19 Patients

Christel Faes et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2020)

Add to Collection

Article Medicine, General & Internal

Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors

Antonio Vena et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Review Public, Environmental & Occupational Health

Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications

Andrew T. Levin et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY (2020)

Add to Collection

Review Multidisciplinary Sciences

Antibody response to SARS-CoV-2 infection in humans: A systematic review

Nathan Post et al.

PLOS ONE (2020)

Add to Collection

Article Public, Environmental & Occupational Health

COVID-19 Outbreak - New York City, February 29-June 1, 2020

Corinne N. Thompson et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Add to Collection

Article Multidisciplinary Sciences

Age-specific mortality and immunity patterns of SARS-CoV-2

Megan O'Driscoll et al.

NATURE (2020)

Add to Collection

Article Immunology

Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020

Manoj V. Murhekar et al.

INDIAN JOURNAL OF MEDICAL RESEARCH (2020)

Add to Collection

Article Public, Environmental & Occupational Health

Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) - China, 2020

Zijian Feng et al.

CHINA CDC WEEKLY (2020)

Add to Collection

Article Hematology

Sociodemographic and behavioral characteristics associated with blood donation in the United States: a population-based study

Eshan U. Patel et al.

TRANSFUSION (2019)

Add to Collection

Review Immunology

The human antibody response to influenza A virus infection and vaccination

Florian Krammer

NATURE REVIEWS IMMUNOLOGY (2019)

Add to Collection

Article Demography

Racial and Ethnic Disparities in Health Insurance Coverage: Dynamics of Gaining and Losing Coverage Over the Life-Course

Heeju Sohn

POPULATION RESEARCH AND POLICY REVIEW (2017)

Add to Collection

Article Health Care Sciences & Services

Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data

Zachary Munn et al.

INTERNATIONAL JOURNAL OF EVIDENCE-BASED HEALTHCARE (2015)

Add to Collection

Editorial Material Medicine, General & Internal

Research methodology - Reasons or excuses for avoiding meta-analysis in forest plots

John P. A. Ioannidis et al.

BMJ-BRITISH MEDICAL JOURNAL (2008)

Add to Collection

© Peeref 2019-2024. All rights reserved.